Letter to National Governors Association leaders and all governors stresses the importance of establishing certainty that flexibilities established early in the pandemic will be sustained.
NACDS issues an open letter to Congress urging a necessary step to help scale and sustain COVID-19 testing.
Chain Drug Review published NACDS President & CEO Steven C. Anderson's report on NACDS' COVID-19 advocacy.
The NACDS Board of Directors on July 8 held a “virtual” meeting with Department of Health and Human Services Assistant Secretary for Health ADM Brett P. Giroir, M.D.
NACDS, national pharmacy groups request clarity from HHS surrounding pharmacists’ vaccination authority under the PREP Act.
On June 24, the NACDS Board of Directors “virtually” met with eight key members of the Administration and Congress.
FMI, NACDS, NCPA, NGA, and PCMA today issued the following joint statement outlining the best practices for pharmacies and PBMs to follow for documenting signature-free delivery or pick-up of prescription drugs during the Public Health Emergency related to the COVID-19 pandemic.
The Community Pharmacy Association of New York State and NACDS are hailing a new law that will ensure pharmacists can provide to New Yorkers the COVID-19 vaccine when it becomes available.
Full preparedness for pharmacist-provided flu vaccines also a priority as flu and coronavirus could collide this Fall.
National group representing 40,000 pharmacies with 155,000 pharmacists cites federal study: U.S. can vaccinate 80 percent of the nation seven weeks sooner by using pharmacies.
